Clinical Trial Update: Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (TUKIS) is evaluating tenecteplase plus urinary kallidinogenase for acute ischemic stroke and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)
• Urinary kallidinogenase (urinary kallidinogenase)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Ischemic Stroke | Phase 2 | Status: RECRUITING